Study summary · research use only
Diagnostic accuracy of the triptorelin stimulation test for central precocious puberty in girls
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This retrospective human study in girls evaluated the diagnostic accuracy of subcutaneous triptorelin versus intravenous gonadorelin for central precocious puberty (CPP), measuring gonadotropins by electrochemiluminescence assay before and after stimulation in 341 girls (102 given triptorelin, 239 given gonadorelin); 143 were diagnosed with CPP and 198 with non-progressive thelarche. Triptorelin produced higher FSH peaks than gonadorelin, with comparable LH peaks and higher FSH/LH ratios. An LH peak cut-off of 7.14 IU/L after triptorelin gave sensitivity 94% and specificity 96% (AUC 0.985); a 4.7 IU/L cut-off after gonadorelin gave sensitivity 100% and specificity 87% (AUC 0.982). Peak LH occurred mostly at 180 minutes after triptorelin. The authors describe triptorelin as comparable in diagnostic accuracy to gonadorelin in this retrospective, non-parallel cohort.
Abstract
Central precocious puberty (CPP) results from premature activation of the hypothalamic-pituitary-gonadal axis. The GnRH stimulation test remains the diagnostic gold standard, especially in girls with undetectable basal LH levels. However, native GnRH is expensive and often unavailable. Rapid-acting subcutaneous triptorelin has been proposed as a reliable alternative. This retrospective study evaluated the diagnostic accuracy of subcutaneous triptorelin compared with intravenous gonadorelin and investigated the optimal timing for LH peak assessment. A total of 341 girls referred for suspected precocious puberty were evaluated: 102 underwent the triptorelin test and 239 the gonadorelin test, with gonadotropins measured by electrochemiluminescence assay at baseline and after stimulation. Based on clinical, radiological, and laboratory criteria, 143 girls were diagnosed with CPP and 198 with non-progressive thelarche (NPT). Triptorelin elicited significantly higher FSH peaks than gonadorelin, while LH peaks were comparable; consequently, FSH/LH ratios were higher after triptorelin. ROC analysis identified an optimal diagnostic LH peak cut-off of 7.14 IU/L following triptorelin administration (sensitivity 94%, specificity 96%; AUC 0.985), while a threshold of 4.7 IU/L was observed after gonadorelin (sensitivity 100%, specificity 87%; AUC 0.982). Peak LH occurred predominantly at 180 min after triptorelin in both CPP and NPT groups (78 and 90%, respectively). Despite the limitations of its retrospective and non-parallel design, this large cohort study demonstrates that subcutaneous triptorelin provides excellent diagnostic accuracy, comparable to gonadorelin. These findings support triptorelin as a reliable and accessible alternative for CPP diagnosis and contribute to the standardization of diagnostic protocols in clinical practice. This study tested triptorelin stimulation as an alternative to the standard gonadorelin test to diagnose precocious puberty in girls. Triptorelin proved equally accurate and reliable, especially when hormone levels are measured 3 h after injection, offering a practical diagnostic tool in clinical practice.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.